These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6241211)
41. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives. Emrich HM; Berger M; Riemann D; von Zerssen D Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909 [TBL] [Abstract][Full Text] [Related]
42. Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. Johnson MR; Lydiard RB; Morton WA; Laird LK; Steele TE; Kellner CH; Ballenger JC J Psychiatr Res; 1993; 27(2):161-72. PubMed ID: 8396179 [TBL] [Abstract][Full Text] [Related]
43. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. Nathan RS; Perel JM; Pollock BG; Kupfer DJ J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201 [TBL] [Abstract][Full Text] [Related]
44. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Mullin JM; Pandita-Gunawardena VR; Whitehead AM Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864 [No Abstract] [Full Text] [Related]
45. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man. Saletu B; Grünberger J; Rajna P; Karobath M J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458 [TBL] [Abstract][Full Text] [Related]
46. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663 [TBL] [Abstract][Full Text] [Related]
47. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735 [TBL] [Abstract][Full Text] [Related]
48. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression. de Jonghe F; Swinkels J; Tuynman-Qua H Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418 [TBL] [Abstract][Full Text] [Related]
49. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study. Suominen J; Tamminen T; Elosuo R; Manniche PM Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246 [TBL] [Abstract][Full Text] [Related]
50. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder. Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925 [TBL] [Abstract][Full Text] [Related]
51. A double-blind comparison of paroxetine, imipramine, and placebo in major depression. Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825 [TBL] [Abstract][Full Text] [Related]
52. Nefazodone and imipramine in major depression: a placebo-controlled trial. Rickels K; Schweizer E; Clary C; Fox I; Weise C Br J Psychiatry; 1994 Jun; 164(6):802-5. PubMed ID: 7952987 [TBL] [Abstract][Full Text] [Related]
53. Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study. Baldwin DS; Green M; Montgomery SA Int Clin Psychopharmacol; 2014 Nov; 29(6):339-43. PubMed ID: 24859491 [TBL] [Abstract][Full Text] [Related]
54. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Feighner JP; Boyer WF J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824 [TBL] [Abstract][Full Text] [Related]
55. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients. Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774 [TBL] [Abstract][Full Text] [Related]
56. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044 [TBL] [Abstract][Full Text] [Related]
57. A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression. Faltus F; Geerling FC Neuropsychobiology; 1984; 12(1):34-8. PubMed ID: 6239991 [TBL] [Abstract][Full Text] [Related]
58. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice. Hamilton BA; Jones PG; Hoda AN; Keane PM; Majid I; Zaidi SI Pharmatherapeutica; 1989; 5(5):292-7. PubMed ID: 2501801 [TBL] [Abstract][Full Text] [Related]
59. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. Merideth CH; Feighner JP; Hendrickson G J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981 [TBL] [Abstract][Full Text] [Related]
60. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders. Salzmann E; Robin JL Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]